Refinement of prognosis and the effect of azacitidine in intermediate-risk myelodysplastic syndromes

Refinement of prognosis and the effect of azacitidine in intermediate-risk myelodysplastic syndromes

Bibliographic Details
Main Authors:	Konstantinos Liapis, Vasileios Papadopoulos, George Vrachiolias, Athanasios G. Galanopoulos, Menelaos Papoutselis, Sotirios G. Papageorgiou, Panagiotis T. Diamantopoulos, Vassiliki Pappa, Nora-Athina Viniou, Alexandra Kourakli, Dimitris Τsokanas, Theodoros P. Vassilakopoulos, Eleftheria Hatzimichael, Eleni Bouronikou, Maria Ximeri, Charalambos Pontikoglou, Aekaterini Megalakaki, Panagiotis Zikos, Panayiotis Panayiotidis, Maria Dimou, Stamatis Karakatsanis, Maria Papaioannou, Anna Vardi, Flora Kontopidou, Nikolaos Harchalakis, Ioannis Adamopoulos, Argiris Symeonidis, Ioannis Kotsianidis
Format:	Article
Language:	English
Published:	Nature Publishing Group 2021-02-01
Series:	Blood Cancer Journal
Online Access:	https://doi.org/10.1038/s41408-021-00424-4

Similar Items

Risk factors for cardiovascular disease mortality in patients with myelodysplastic syndromes: A nationwide, registry‐based cohort study
by: Konstantinos Liapis, et al.
Published: (2020-07-01)

The prognostic significance of chromosome 17 abnormalities in patients with myelodysplastic syndrome treated with 5‐azacytidine: Results from the Hellenic 5‐azacytidine registry
by: Panagiotis Diamantopoulos, et al.
Published: (2019-05-01)

Serum ferritin and ECOG performance status predict the response and improve the prognostic value of IPSS or IPSS-R in patients with high-risk myelodysplastic syndromes and oligoblastic acute myeloid leukemia treated with 5-azacytidine: a retrospective analysis of the Hellenic national registry of myelodysplastic and hypoplastic syndromes
by: Sotirios G. Papageorgiou, et al.
Published: (2020-12-01)

Common cardiovascular biomarkers can independently predict outcome of patients with Myelodysplastic syndromes
by: Ioannis Mitroulis, et al.
Published: (2023-05-01)

Real world data on the prognostic significance of monocytopenia in myelodysplastic syndrome
by: Panagiotis T. Diamantopoulos, et al.
Published: (2022-10-01)

P706: RESISTANCE TO HYPOMETHYLATING AGENTS (HMA) IN HIGH-RISKMYELODYSPLASTIC SYNDROME (HR-MDS): THE ROLE OF THE ADENOSINEDEAMINASE ACTING ON RNA 1 (ADAR1) ENZYME
by: Despoina Dimitriou, et al.
Published: (2023-08-01)

A personalized stepwise dynamic predictive algorithm of the time to first treatment in chronic lymphocytic leukemia
by: Theodoros Moysiadis, et al.
Published: (2023-09-01)

P1606: PRIMARY AND SECONDARY IMMUNE THROMBOCYTOPENIA (ITP) IN ADULTS: REAL WORLD COMPARATIVE RETROSPECTIVE STUDY FROM THE ITP REGISTRY OF THE HELLENIC SOCIETY OF HEMATOLOGY
by: Emily Stavroulaki, et al.
Published: (2023-08-01)

P785: CURRENT CARDIOVASCULAR DISEASE RISK PREDICTION MODELS ARE NOT APPLICABLE IN MDS PATIENTS: PRELIMINARY RESULTS OF A PROSPECTIVE OBSERVATIONAL SINGLE-CENTRE COHORT STUDY
by: C. Misidou, et al.
Published: (2022-06-01)

Approach to Acute Myeloid Leukemia with Increased Eosinophils and Basophils
by: Stavros Papadakis, et al.
Published: (2024-02-01)

Epigenetic therapy of myelodysplastic syndromes connects to cellular differentiation independently of endogenous retroelement derepression
by: Anastasiya Kazachenka, et al.
Published: (2019-12-01)

Allogeneic Hematopoietic Stem Cell Transplantation for Mixed or Overlap Myelodysplastic/Myeloproliferative Disorders
by: Argiris Symeonidis, et al.
Published: (2022-08-01)

P1646: PRIMARY IMMUNE THROMBOCYTOPENIA (ITP) IN PATIENTS OLDER THAN 75 YEARS: REAL WORLD DATA FROM THE ITP REGISTRY OF THE HELLENIC SOCIETY OF HEMATOLOGY
by: C. Pontikoglou, et al.
Published: (2022-06-01)

Autophagy mediates the delivery of thrombogenic tissue factor to neutrophil extracellular traps in human sepsis.
by: Konstantinos Kambas, et al.
Published: (2012-01-01)

TACI Mutations in Primary Antibody Deficiencies: A Nationwide Study in Greece
by: Ioannis Kakkas, et al.
Published: (2021-08-01)

Atypical Chronic Myelogenous Leukemia, BCR-ABL1 Negative: Diagnostic Criteria and Treatment Approaches
by: Panagiotis T. Diamantopoulos, et al.
Published: (2021-11-01)

P701: SYSTEMATIC ANALYSIS OF T LYMPHOCYTES IN MYELOID NEOPLASMS
by: Athanasios Tasis, et al.
Published: (2023-08-01)

Rapidly Progressive Pauci-Immune Glomerulonephritis with Aberrant Fibrinoid Necrosis Associated with Atezolizumab, an Immune Check Point Inhibitor: A Case Report and Review of Literature
by: Petros Nikolopoulos, et al.
Published: (2023-01-01)

Myeloid neoplasms with isolated isochromosome 17q: a yet to be defined entity
by: Eleftheria Lamprianidou, et al.
Published: (2017-11-01)

The Role of Methylation in Chronic Lymphocytic Leukemia and Its Prognostic and Therapeutic Impacts in the Disease: A Systematic Review
by: Sevastianos Chatzidavid, et al.
Published: (2024-01-01)

THE ROLE OF LET-7/HMGA2 LINKAGE IN THE PATHOGENESIS AND PROGNOSIS OF MYELODYSPLASTIC NEOPLASMS
by: D. Vlachopoulou, et al.
Published: (2024-01-01)

COVID-19 vs. Cancer Immunosurveillance: A Game of Thrones within an Inflamed Microenviroment
by: Ioannis Liapis, et al.
Published: (2022-09-01)

Mechanisms of Action of Hypomethylating Agents: Endogenous Retroelements at the Epicenter
by: Chryssoula Kordella, et al.
Published: (2021-03-01)

Autophagy in Neutrophils: From Granulopoiesis to Neutrophil Extracellular Traps
by: Panagiotis Skendros, et al.
Published: (2018-09-01)

Plant communities and habitat types in the protected area of Lake Pamvotis (Epirus, Northwestern Greece)
by: Maria Sarika, et al.
Published: (2020-09-01)

Exploring the effect of remixing stories and games on the development of students' computational thinking
by: Ioannis Vourletsis, et al.
Published: (2022-12-01)

Adoptive Cellular Transfer Immunotherapies for Cancer
by: Panagiotis Parsonidis, et al.
Published: (2022-01-01)

Ψηφιακά Άβαταρ: Μια Μεταφαινομενολογική Προσέγγιση της Βύθισης
by: Ioannis Kalligeris, et al.
Published: (2017-04-01)

Can detection and prediction models for Alzheimer’s Disease be applied to Prodromal Parkinson’s Disease using explainable artificial intelligence? A brief report on Digital Neuro Signatures. [version 1; peer review: 2 approved]
by: Ioannis TARNANAS, et al.
Published: (2021-12-01)

Environmental assessment of ouzo production in Greece: A Life Cycle Assessment approach
by: Panagiotis Tsarouhas, et al.
Published: (2021-12-01)

Superhydrophobic surfaces
by: Karapanagiotis Ioannis, et al.
Published: (2012-11-01)

Poor Neutralizing Antibody Responses in 132 Patients with CLL, NHL and HL after Vaccination against SARS-CoV-2: A Prospective Study
by: Evangelos Terpos, et al.
Published: (2021-09-01)

Chronic Neutrophilic Leukemia: A Comprehensive Review of Clinical Characteristics, Genetic Landscape and Management
by: Thomas P. Thomopoulos, et al.
Published: (2022-04-01)

Nanoparticle Emission and Characterization from Pre-Dried Lignite and Bituminous Coal Co-Combustion
by: Ioannis Avagianos, et al.
Published: (2020-05-01)

Novel Therapeutic Advances in β-Thalassemia
by: Alexandros Makis, et al.
Published: (2021-06-01)

Correlation between Cancer Stem Cells and Circulating Tumor Cells and Their Value
by: Maria Toloudi, et al.
Published: (2011-01-01)

A Reference Model for Cyber Threat Intelligence (CTI) Systems
by: Georgios Sakellariou, et al.
Published: (2022-04-01)

Genistein as a dietary supplement; formulation, analysis and pharmacokinetics study.
by: Alexandra Mamagkaki, et al.
Published: (2021-01-01)

The genetics of myelodysplastic syndromes and the opportunities for tailored treatments
by: Christina-Nefeli Kontandreopoulou, et al.
Published: (2022-10-01)

MRD Monitoring by Multiparametric Flow Cytometry in AML: Is It Time to Incorporate Immune Parameters?
by: Ilias Pessach, et al.
Published: (2022-09-01)